- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Chugai Pharmaceutical
Total 19700 results
-
Chugai PharmaceuticalCompletedRheumatoid Arthritis
-
Chugai PharmaceuticalCompletedHemodialysis PatientsJapan
-
Chugai PharmaceuticalCompleted
-
Chugai PharmaceuticalCompleted
-
Gilead SciencesChugai PharmaceuticalCompletedHepatitis C Virus InfectionJapan
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingAtypical Hemolytic Uremic SyndromeCanada, United States, Belgium, Japan, France, Spain, Mexico, Peru, Brazil, New Zealand, China, Germany, Hungary, Israel, Italy, Poland, South Africa, Turkey, India
-
Hoffmann-La RocheChugai PharmaceuticalActive, not recruitingParoxysmal Nocturnal HemoglobinuriaSpain, Korea, Republic of, France, Sweden, Thailand, Malaysia, China, Turkey, Netherlands, Japan, Australia, United Kingdom, Germany, Brazil, Romania, Argentina, Poland, Greece, Hong Kong, Lithuania, Mexico, Philippines, Portugal, Sin... and more
-
Hoffmann-La RocheChugai PharmaceuticalCompletedBreast CancerKorea, Republic of, Canada, Brazil, Germany, Italy, Spain, Japan, Czechia, Poland, United States, Russian Federation, Taiwan
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AUnited States, Belgium, Spain, Japan, Poland, Australia
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AAustralia, Taiwan, Korea, Republic of, France, Germany, Italy, South Africa, Spain, United States, Japan, Ireland, Poland, United Kingdom, Costa Rica
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AKorea, Republic of, United States, France, Germany, Italy, South Africa, Spain, Japan, United Kingdom, Poland, Taiwan, Australia, Costa Rica, New Zealand
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingGeneralized Myasthenia GravisFrance, Korea, Republic of, China, Argentina, Spain, Brazil, Russian Federation, Japan, Denmark, Australia, Italy, Turkey, Germany, United States, Netherlands, Taiwan, Poland, Canada
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingAtypical Hemolytic Uremic SyndromeUnited States, Belgium, China, France, Spain, Canada, South Africa, Japan, Brazil, Italy, Poland, India, Hungary, Mexico, Israel
-
Hoffmann-La RocheChugai PharmaceuticalActive, not recruitingParoxysmal Hemoglobinuria, NocturnalFrance, Korea, Republic of, Italy, Japan, Germany, Hungary, Netherlands
-
Hoffmann-La RocheChugai PharmaceuticalCompletedMacular Edema | Branch Retinal Vein OcclusionUnited States, Korea, Republic of, Brazil, Japan, United Kingdom, China, Argentina, Australia, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Czechia, Hong Kong, Israel, Portugal, Russian Federation, Taiwan
-
Hoffmann-La RocheChugai PharmaceuticalCompletedNeuromyelitis Optica (NMO) | NMO Spectrum Disorder (NMOSD)Spain, Italy, United States, Japan, Poland, Taiwan, Germany, United Kingdom, Hungary, France, Ukraine
-
RWTH Aachen UniversityChugai PharmaceuticalTerminated
-
Hoffmann-La RocheChugai PharmaceuticalCompleted
-
Chugai PharmaceuticalHoffmann-La RocheCompletedHepatocellular CarcinomaUnited States, Taiwan
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingCarcinoma, HepatocellularUnited States, Canada, Korea, Republic of, Taiwan, Brazil, Belgium, China, Japan, New Zealand, Singapore, Mexico, Spain, Germany, Poland, Thailand, France, Turkey, Italy, Puerto Rico, Hong Kong, South Africa, Côte D'Ivoire
-
Genentech, Inc.Chugai Pharmaceutical Co.RecruitingGastric Cancer | Metastatic Solid Tumor | Non-small Cell Lung Cancer | Pancreatic Ductal AdenocarcinomaKorea, Republic of, Spain, Japan, New Zealand, Australia, United States, Italy, Brazil
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)Canada, United States, Korea, Republic of, Australia, Japan, Italy, Brazil, Germany, France, China, Israel
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingParoxysmal Nocturnal HemoglobinuriaUnited States, Korea, Republic of, Spain, Germany, Italy, Sweden, Netherlands, Japan, Belgium, Greece, Colombia, Saudi Arabia, Turkey, Poland, Ireland, Brazil, Canada, Czechia, Estonia, France, Hong Kong, Singapore, Taiwan, United Kingdom and more
-
Hoffmann-La RocheChugai PharmaceuticalCompletedCentral Retinal Vein Occlusion | Macular Edema | Hemiretinal Vein OcclusionUnited States, Korea, Republic of, Brazil, Japan, United Kingdom, China, Argentina, Australia, France, Hungary, Italy, Poland, Spain, Singapore, Austria, Czechia, Germany, Hong Kong, Israel, Portugal, Russian Federation, Taiwan
-
Hoffmann-La RocheChugai PharmaceuticalCompletedNeuromyelitis Optica (NMO) | NMO Spectrum Disorder (NMOSD)United States, Korea, Republic of, Malaysia, Turkey, Bulgaria, Canada, Poland, Puerto Rico, Romania, Croatia, Georgia, Italy, Philippines, Taiwan, Ukraine
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AUnited States, France, Germany, Italy, South Africa, Spain, Turkey, Japan, United Kingdom, Costa Rica
-
University Hospital, BrestChugai PharmaceuticalCompleted
-
Hoffmann-La RocheChugai PharmaceuticalCompletedGastric CancerBelgium, France, Italy, Spain, China, Costa Rica, Denmark, Germany, Portugal, Taiwan, United Kingdom, Russian Federation, Korea, Republic of, Peru, Turkey, Mexico, Australia, Brazil, Finland, Guatemala, India, Japan, Panama, South Africa
-
Chugai PharmaceuticalJapan Lung Cancer SocietyCompletedNon-small Cell Lung Cancer | Extensive Disease Small Cell Lung CancerJapan
-
Chugai PharmaceuticalClinica Medicina da MulherCompleted
-
Chugai PharmaceuticalYakult Honsha Co., LTDCompletedColorectal CancerJapan
-
Hoffmann-La RocheChugai Pharmaceutical Co.RecruitingNMDAR Autoimmune Encephalitis | LGI1 Autoimmune EncephalitisUnited States, Korea, Republic of, China, Japan, Czechia, Italy, Poland, Austria, Brazil, Argentina, Netherlands, Taiwan, France, Denmark, Ghana
-
Chugai PharmaceuticalJapan Lung Cancer SocietyCompletedNon-small Cell Lung Cancer | Extensive Disease Small Cell Lung CancerJapan
-
Chugai PharmaceuticalNational Cancer Institute (NCI)CompletedPain | Breast Cancer | Metastatic Cancer | Hypercalcemia of MalignancyUnited States
-
Hoffmann-La RocheChugai Pharmaceutical Co.TerminatedNeuromyelitis Optica Spectrum Disorder | NMOSDUnited States, Korea, Republic of, Italy, Canada, Japan, Turkey
-
Chugai PharmaceuticalJapan Lung Cancer SocietyCompletedA Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)Non-small-Cell Lung CancerJapan
-
Biofourmis Singapore Pte Ltd.Chugai PharmaceuticalCompletedEndometriosisUnited States, Singapore, Taiwan
-
Japanese Foundation for Cancer ResearchChugai PharmaceuticalActive, not recruiting
-
Japan Breast Cancer Research GroupChugai PharmaceuticalUnknownHER2-positive Locally Advanced or Metastatic Breast CancerJapan
-
Genentech, Inc.Hoffmann-La Roche; Chugai PharmaceuticalCompleted
-
Japan Breast Cancer Research GroupChugai PharmaceuticalCompletedMetastatic Breast CancerJapan
-
Assistance Publique - Hôpitaux de ParisChugai PharmaceuticalCompleted
-
Institut BergoniéBristol-Myers Squibb; Amgen; Aventis Pharmaceuticals; Sanofi-Synthelabo; Chugai PharmaceuticalCompletedDigestive System Diseases | Lymphoma | Ovarian Diseases | Pulmonary Disease | Bladder Disease | Prostatic DiseaseFrance
-
HaemnetRoche ChugaiCompletedHemophilia A With InhibitorUnited Kingdom
-
Chugai Pharma USACompletedAtherosclerosis | Coronary Restenosis | Graft Occlusion, VascularUnited States
-
Chugai Pharma USACompletedBreast Cancer | Breast Neoplasms | MetastasisUnited States
-
Chugai Pharma USACompletedGastroparesisUnited States
-
Chugai Pharma TaiwanCompletedHemodialysis | Hyperphosphatemia | Cardiovascular Events
-
Chugai Pharma TaiwanCompletedRheumatoid ArthritisTaiwan
-
Chugai Pharma TaiwanCompletedRheumatoid Arthritis (RA)Taiwan